Thus, the TRAFD1-4:1/miR-27a-3p/CXCL1 axis has been established, wherein the action of an lncRNA (TRAFD1-4:1) modulates the activity of a gene (CXCL1), producing beneficial effects in RA. This evidence concerns the gene CXCL1 and rheumatoid arthritis.